what worries me most is the real possibility that their revs will fall to below $60 million and net profit margins will dive to 10% to 15%... so we'll have a terrible beginning to the promised year... but the huge building will continue to be a drag for another 6 months, or perhaps they will be out of cash to complete it. and they are stuck with inability to invest in developing their patented drugs and the competition kills them where there are no exclusive rights. so the situation is very shaky.
News 
Market Data 
Discover 
